EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, STOK: Stoke Therapeutics Inc

19 Dec 25 15:59
LAST:

31.95

CHANGE:
 0.03		OPEN:
31.93		HIGH:
33.16		ASK:
0.00		VOLUME:
448.7K
CHG(%):
0.09		PREV:
31.93		LOW:
31.55		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 2531.8133.1631.5531.962.96M
18 Dec 2533.2833.8831.5031.93739.7K
17 Dec 2533.6034.0532.4332.86851.9K
16 Dec 2532.5233.9332.4033.61645.6K
15 Dec 2533.1335.4332.4732.98934.6K
12 Dec 2533.3333.7732.2632.391.17M
11 Dec 2533.8535.4032.9333.091.06M
10 Dec 2531.1135.3430.1734.151.82M
09 Dec 2532.7333.3430.3730.471.31M
08 Dec 2531.2833.3030.9033.001.02M

PROFILE

Name:Stoke Therapeutics Inc
About:Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:45 Wiggins Avenue, Bedford, MA, United States, 01730
Website:https://www.stoketherapeutics.com
CUSIP:86150R107
CIK:0001623526
ISIN:US86150R1077
FIGI:BBG00JPCBPG9
LEI:549300RD25SS2DIJHJ67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:34.53 
Forward P/E:-12.11 
PEG Ratio:-2.65 
Price to Sales:8.24 
Price to Book:4.91 
Profit Margin:0.26 
Operating Margin:-1.98 
Return on Assets:0.07 
Return on Equity:0.18 
EPS Ratio:0.87 
Revenue:199.89M 
EBITDA:42.27M 
Shares:54.8M 
Market Cap:1.751B 

TECHNICAL INDICATORS

MA5:32.672.2%
MA10:32.642.2%
MA20:31.541.3%
MA50:30.215.8%
MA100:25.3526.0%
MA200:17.6381.2%
STO9:30.04
STO14:38.26
RSI14:56.35
WPR14:-50.46
MTM14:2.15
ROC14:0.07 
ATR:2.25 
Week High:35.4310.9%
Week Low:31.501.4%
Month High:35.4310.9%
Month Low:27.5381.2%
Year High:38.6921.1%
Year Low:5.35497.2%